Category Archives: Clinical Cardiology

This transcript has been edited for clarity and is a continuation of Drs Harrington and Gibson's discussion Cardiology 2019: Top Trials in Review. Robert A. Harrington, MD: Hi. Continue reading →

MUNICH--(BUSINESS WIRE)--415 CAPITAL Management GmbH (415 CAPITAL) today announced it has held a first closing of its new MedTech Venture Capital fund (415 CAPITAL Fund I). The new fund will invest in medical device companies in Europe, Israel and the United States, with a focus on startups developing groundbreaking technologies to diagnose and treat Cardiovascular disease and its associated risk factors, including coronary artery disease, structural heart disease, stroke, hypertension and vascular disease. The fund will hold a final closing at up to $100 million (85 million) later in 2020 Continue reading →

Feeling exhausted, irritable, and dejected all the time aka burnout is not good for your mental well-being. Continue reading →

Shift in dietary practices needed to fight epidemic of heart diseases in Pakistan Dietary practices are a major risk factor for cardiovascular diseases and diabetes in Pakistan because health practitioners have difficulty translating international recommendations according to local diet. Continue reading →

NEW YORK, Jan. 14, 2020 /PRNewswire/ -- Three new medical offices have recently joined NYU Langone Heath's rapidly expanding ambulatory care network, enhancing access to premier outpatient medical care directly in the communities where patients live and work. Continue reading →

The latest data on the main causes of death after stroke will be presented at ESC Heart & Stroke 2020. The international conference of the European Society of Cardiology (ESC) Council on Stroke is endorsed by the European Stroke Organisation (ESO) Continue reading →

The increase in minimal microvascular resistance that occurs with age may result in progressive impaired capacity of coronary vasodilation in the pan myocardial region, and may affect ischemic heart disease pathophysiology, according to a study published in JACC: Cardiovascular Interventions. This study included 327 patients (with a total of 419 stenosed vessels), all of whom had a clinical indication for physiological examination of at least 1 intermediate angiographic severity Continue reading →

Non-vitamin K antagonist oral anticoagulants (NOACs) may be associated with lower risks for adverse events requiring hospitalization and reduced rates of major bleeding compared with vitamin K antagonists in patients receiving percutaneous coronary intervention (PCI) for non-valvular atrial fibrillation who have an indication for anticoagulation, according to study results published in Cochrane Database Systematic Review. In this systematic review and network meta-analysis, the data of randomized controlled trials indexed in CENTRAL, MEDLINE, Embase, the Conference Proceedings Citation Index Science, and 2 clinical trial registers, in which the outcomes of patients with an indication for anticoagulation who had undergone PCI and treated with NOACs vs vitamin K antagonists were examined. The final network meta-analysis included 5 randomized controlled trials with a pooled cohort of 8373 participants. Continue reading →

Habitual tea consumption is associated with lower risk of cardiovascular disease and death, according to a study published last week in the European Journal of Preventive Cardiology. Continue reading →

Cardiologs, a French medical technology startup thats leveraging artificial intelligence (AI) to help detect heart conditions, has raised $15 million in series A funding. The round was led by Paris-based venture capital (VC) firm Alven, which touts its credentials for helping French-founded startups expand into the U.S. Other participants include Bpifrance, Idinvest Partners, Kurma Diagnostics, ISAI, and Paris Saclay Seed Fund. Continue reading →